Justera Health Ltd. (VTAL.CX)
0.005
0.00 (0.00%)
CAD |
CNSX |
Feb 24, 16:00
Justera Health Cash from Financing (Quarterly) : -0.80M for Dec. 31, 2024
Cash from Financing (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Cash From Financing Definition
Cash flow from financing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall financing activities of the company. A few examples of financing activities include common stock issuance, total dividends paid, and net debt issuance.
Cash from Financing (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Financing (Quarterly) Benchmarks
| BioMark Diagnostics, Inc. | -0.0582M |
| Neural Therapeutics, Inc. | -- |
| ARCpoint, Inc. | 0.1566M |
| Arch Biopartners, Inc. | 0.0925M |
| Biocure Technology, Inc. | 0.0004M |
Cash from Financing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | 0.6991M |
| Cash from Investing (Quarterly) | 0.1499M |